Business Context and Reporting Period
Company: TPG Specialty Lending, Inc. (Note: Input metadata referenced "Sixth Street," but the filing text identifies the registrant as TPG Specialty Lending, Inc., trading as TSLX).
Reporting Period: Fiscal year ended December 31, 2014.
Business Overview: The Company is an externally managed, closed-end, non-diversified management investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). It focuses on lending to U.S.-domiciled middle-market companies, primarily through direct originations of senior secured loans (first-lien and second-lien), mezzanine debt, and equity securities. As of December 31, 2014, the portfolio consisted of 34 companies with a weighted average annual EBITDA of $34 million.
Key Financial Metrics
| Metric | 2014 | 2013 |
|---|---|---|
| Total Investment Income | $163.3 million | $92.6 million |
| Net Investment Income | $104.4 million | $57.5 million |
| Net Realized Gains (Losses) | ($1.7) million | $1.1 million |
| Net Change in Unrealized Gains (Losses) | ($17.7) million | $8.4 million |
| Net Assets Resulting from Operations | $85.0 million | $67.0 million |
| Earnings Per Share (Basic & Diluted) | $1.68 | $1.93 |
| Total Assets | $1,303.7 million | $1,039.2 million |
| Investments at Fair Value | $1,263.5 million | $1,016.5 million |
| Total Debt Outstanding | $395.9 million | $432.3 million |
| Asset Coverage Ratio | 311.0% | 232.9% |
| Weighted Average Yield (Fair Value) | 10.3% | 10.4% |
| Dividends Declared Per Share | $1.53 | $1.56 |
Material Changes vs. Prior Period
- Portfolio Growth: Investments at fair value increased by approximately 24% to $1.26 billion, driven by new investment commitments of $884.4 million in 2014 compared to $606.2 million in 2013. The number of portfolio companies grew from 27 to 34.
- Income Increase: Total investment income rose 76% to $163.3 million, primarily due to the larger portfolio size and increased prepayment fees ($21.0 million in 2014 vs. $3.0 million in 2013).
- Expense Growth: Net expenses increased to $57.7 million from $34.9 million. This was driven by higher interest expense ($15.1 million vs. $10.5 million) and increased incentive fees ($17.8 million vs. $11.8 million) following the IPO and portfolio expansion.
- Unrealized Losses: The Company recorded a net change in unrealized losses of $17.7 million in 2014, a reversal from the $8.4 million gain in 2013. This was attributed to a widening spread environment in the second half of 2014 and negative credit-related adjustments.
- Capital Structure: The Company completed its IPO in March 2014, raising approximately $167 million in net proceeds. It also issued $115 million in Convertible Senior Notes in June 2014. Total debt outstanding decreased slightly year-over-year due to the use of equity and note proceeds to pay down revolving credit facilities.
Guidance, Outlook, and Risks
- Stock Repurchase Plan: The Board approved a $50 million stock repurchase plan (Company 10b5-1 Plan) in November 2014 to acquire shares trading below net asset value (NAV). As of December 31, 2014, no shares had been repurchased under this plan. The plan was extended to June 30, 2015.
- Dividend Policy: The Company intends to distribute substantially all earnings to maintain RIC status. Dividends are declared quarterly. The Company has an "opt-out" dividend reinvestment plan.
- Key Risks:
- Interest Rate Risk: Approximately 96.8% of debt investments are floating rate. While this hedges against inflation, rising rates increase borrowing costs. The Company uses interest rate swaps to align liabilities with assets.
- Valuation Risk: A significant portion of the portfolio (Level 3 assets) is valued using unobservable inputs, introducing subjectivity and potential volatility in NAV.
- Liquidity Risk: Investments are generally illiquid. The Company relies on credit facilities and cash flows to meet obligations.
- Regulatory Risk: As a BDC, the Company is subject to asset coverage requirements (minimum 200%) and distribution requirements to maintain RIC tax status.
- Management Commentary: Management noted that the widening spread environment in late 2014 impacted unrealized values. However, the portfolio remains well-diversified across 19 industries, with healthcare and pharmaceuticals being the largest sector (17.3%).
Important Facts for Investor Verification
- Unrealized Depreciation: Verify the specific portfolio companies contributing to the $17.7 million net unrealized loss, particularly those with negative credit-related or energy-related adjustments mentioned in the MD&A.
- Prepayment Fees: Confirm the sustainability of the $21.0 million in prepayment fees recognized in 2014, as this was a significant driver of income growth compared to prior years.
- Debt Covenants: Review the specific financial covenants of the Revolving Credit Facility and SPV Asset Facility to ensure continued compliance, especially regarding the asset coverage ratio and liquidity tests.
- Convertible Notes: Assess the dilution risk associated with the $115 million Convertible Senior Notes (conversion price ~$25.83) and the impact of the interest rate swaps on the effective cost of this debt.
- Stock Repurchase Execution: Monitor the execution of the $50 million stock repurchase plan, as no shares were repurchased by year-end 2014.